Impact of loop diuretics on blood sodium in patients hospitalized for heart failure.
- Author:
Yu GUAN
1
;
Xuesi WU
2
;
Min XU
1
;
Jiahui WU
1
Author Information
- Publication Type:Journal Article
- MeSH: Acute Disease; Creatinine; Heart Failure; complications; drug therapy; Humans; Hyponatremia; Risk Factors; Sodium; blood; Sodium Potassium Chloride Symporter Inhibitors; adverse effects; therapeutic use; Sodium, Dietary
- From: Chinese Journal of Cardiology 2014;42(7):582-587
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the level of blood sodium in patients hospitalized for heart failure with water-sodium retention treated with loop diuretics and risk factors of low blood sodium.
METHODSWe selected 1 378 acute decompensated heart failure patients who visited Anzhen Hospital, and they are treated with loop diuretics, 259 patients with weight loses more than 1 kg in one week was enrolled in the final analysis, and divided into 3 groups: Group A (weight reduction between 1-3 kg), Group B (weight reduction between 3-5 kg) and Group C (weight reduction over 5 kg). Blood sodium, creatinine and uric acid were compared among groups and risk factors of low blood sodium were analyzed.
RESULTSBlood sodium was similar before and post loop diuretics treatment in Group A, and reduced in group B ((138.28 ± 3.73) mmol/L vs. (139.34 ± 3.66) mmol/L, P < 0.05) and in Group C((137.60 ± 4.07) mmol/L vs. (139.44 ± 4.12) mmol/L, P < 0.05). Forty-six (17.8%) patients developed hyponatremia post loop diuretics treatment. Duration of loop diuretics use was the independent risk infector for hyponatremia (OR = 1.191, 95%CI 1.010-1.385).
CONCLUSIONSLoop diuretics use is safe for treating hospitalized patients for heart failure with water-sodium retention and the risk of developing hyponatremia is low. Duration of loop diuretics use is the independent risk factor of hyponatremia.